» Articles » PMID: 39741789

Radiomics Based Machine Learning Models for Classification of Prostate Cancer Grade Groups from Multi Parametric MRI Images

Overview
Date 2025 Jan 1
PMID 39741789
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study aimed to investigate the performance of multiparametric magnetic resonance imaging (mpMRI) radiomic feature-based machine learning (ML) models in classifying the Gleason grade group (GG) of prostate cancer.

Methods: In this retrospective study, a total of 203 patients with histopathologically confirmed prostate cancer who underwent mpMRI before prostate biopsy were included. After manual segmentation, radiomic features (RFs) were extracted from T2-weighted, apparent diffusion coefficient, and high b-value diffusion-weighted magnetic resonance imaging (DWMRI). Patients were split into training sets and testing sets according to a ratio of 8:2. A pipeline considering combinations of two feature selection (FS) methods and six ML classifiers was developed and evaluated. The performance of models was assessed using the accuracy, sensitivity, precision, F1-measure, and the area under curve (AUC).

Results: On high b-value DWMRI-derived features, a combination of FS method recursive feature elimination (RFE) and classifier random forest achieved the highest performance for classification of prostate cancer into five GGs, with 97.0% accuracy, 98.0% sensitivity, 98.0% precision, and 97.0% F1-measure. The method also achieved an average AUC for GG of 98%.

Conclusion: Preoperative mpMRI radiomic analysis based on ML, as a noninvasive approach, showed good performance for classification of prostate cancer into five GGs.

Advances In Knowledge: Herein, radiomic models based on preoperative mpMRI and ML were developed to classify prostate cancer into 5 GGs. Our study provides evidence that analysis of quantitative RFs extracted from high b-value DWMRI images based on a combination of FS method RFE and classifier random forest can be applied for multiclass grading of prostate cancer with an accuracy of 97.0%.

References
1.
Michaely H, Aringhieri G, Cioni D, Neri E . Current Value of Biparametric Prostate MRI with Machine-Learning or Deep-Learning in the Detection, Grading, and Characterization of Prostate Cancer: A Systematic Review. Diagnostics (Basel). 2022; 12(4). PMC: 9027206. DOI: 10.3390/diagnostics12040799. View

2.
van Timmeren J, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B . Radiomics in medical imaging-"how-to" guide and critical reflection. Insights Imaging. 2020; 11(1):91. PMC: 7423816. DOI: 10.1186/s13244-020-00887-2. View

3.
Smith C, Czarniecki M, Mehralivand S, Stoyanova R, Choyke P, Harmon S . Radiomics and radiogenomics of prostate cancer. Abdom Radiol (NY). 2018; 44(6):2021-2029. DOI: 10.1007/s00261-018-1660-7. View

4.
Ahmed H, El-Shater Bosaily A, Brown L, Gabe R, Kaplan R, Parmar M . Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017; 389(10071):815-822. DOI: 10.1016/S0140-6736(16)32401-1. View

5.
Futterer J, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A . Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. Eur Urol. 2015; 68(6):1045-53. DOI: 10.1016/j.eururo.2015.01.013. View